Factors associated with engagement and adherence to a low-energy diet to promote 10% weight loss in patients with clinically significant non-alcoholic fatty liver disease

Objective Clinical guidelines recommend weight loss to manage non-alcoholic fatty liver disease (NAFLD). However, the majority of patients find weight loss a significant challenge. We identified factors associated with engagement and adherence to a low-energy diet (LED) as a treatment option for NAFLD. Design 23 patients with NAFLD enrolled in a LED (~800 kcal/day) were individually interviewed. Transcripts were thematically analysed. Results 14/23 patients achieved ≥10% weight loss, 18/23 achieved ≥7% weight loss and 19/23 achieved ≥5% weight loss. Six themes were generated from the data. A desire to achieve rapid weight loss to improve liver health and prevent disease progression was the most salient facilitator to engagement. Early and significant weight loss, accountability to clinicians and regular appointments with personalised feedback were facilitators to engagement and adherence. The desire to receive positive reinforcement from a consultant was a frequently reported facilitator to adherence. Practical and emotional support from friends and family members was critically important outside of the clinical setting. Irregular working patterns preventing attendance at appointments was a barrier to adherence and completion of the intervention. Conclusions Engagement and adherence to a LED in patients with NAFLD were encouraged by early and rapid weight loss, personalised feedback and positive reinforcement in the clinical setting combined with ongoing support from friends and family members. Findings support those identified in patients who completed a LED to achieve type 2 diabetes remission and highlight the importance of behaviour change support during the early stages of a LED to promote adherence.

[1]  S. Jebb,et al.  Participant experiences of a low-energy total diet replacement programme: A descriptive qualitative study , 2020, PloS one.

[2]  M. Trenell,et al.  Feasibility of a Very Low Calorie Diet to Achieve a Sustainable 10% Weight Loss in Patients With Nonalcoholic Fatty Liver Disease , 2020, Clinical and translational gastroenterology.

[3]  M. Moura-Ramos,et al.  Insights from qualitative research on NAFLD awareness with a cohort of T2DM patients: time to go public with insulin resistance? , 2020, BMC Public Health.

[4]  G. Frost,et al.  Low-energy total diet replacement intervention in patients with type 2 diabetes mellitus and obesity treated with insulin: a randomized trial , 2020, BMJ Open Diabetes Research & Care.

[5]  F. Sniehotta,et al.  Behaviour change during dietary Type 2 diabetes remission: a longitudinal qualitative evaluation of an intervention using a very low energy diet , 2020, Diabetic medicine : a journal of the British Diabetic Association.

[6]  P. Burton,et al.  Improving Compliance with Very Low Energy Diets (VLEDs) Prior to Bariatric Surgery—a Randomised Controlled Trial of Two Formulations , 2019, Obesity Surgery.

[7]  S. Dombrowski,et al.  Using the theoretical domains framework to identify barriers and enabling factors to implementation of guidance for the diagnosis and management of nonalcoholic fatty liver disease: a qualitative study , 2019, Translational behavioral medicine.

[8]  A. Brown,et al.  Very low‐energy and low‐energy formula diets: Effects on weight loss, obesity co‐morbidities and type 2 diabetes remission – an update on the evidence for their use in clinical practice , 2019, Nutrition Bulletin.

[9]  P. Galle,et al.  Health-related Quality of Life in Non-alcoholic Fatty Liver Disease Associates With Hepatic Inflammation. , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[10]  S. Jebb,et al.  Doctor Referral of Overweight People to Low Energy total diet replacement Treatment (DROPLET): pragmatic randomised controlled trial , 2018, British Medical Journal.

[11]  A. Grunseit,et al.  Experiences of using very low energy diets for weight loss by people with overweight or obesity: a review of qualitative research , 2018, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[12]  Roy Taylor,et al.  Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial , 2017, The Lancet.

[13]  L. Henry,et al.  NAFLD AND NASH: Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention , 2018 .

[14]  J. Holst,et al.  Instrumentalization of Eating Improves Weight Loss Maintenance in Obesity , 2017, Obesity Facts.

[15]  M. Trenell,et al.  Lifestyle Behavior Change in Patients With Nonalcoholic Fatty Liver Disease: A Qualitative Study of Clinical Practice , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[16]  F. Sniehotta,et al.  Acceptability of a very‐low‐energy diet in Type 2 diabetes: patient experiences and behaviour regulation , 2017, Diabetic medicine : a journal of the British Diabetic Association.

[17]  F. Sniehotta,et al.  Efficacy and acceptability of very low energy diets in overweight and obese people with Type 2 diabetes mellitus: a systematic review with meta‐analyses , 2016, Diabetic medicine : a journal of the British Diabetic Association.

[18]  Benjamin Aribisala,et al.  Very Low-Calorie Diet and 6 Months of Weight Stability in Type 2 Diabetes: Pathophysiological Changes in Responders and Nonresponders , 2016, Diabetes Care.

[19]  S. Friedman,et al.  Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis. , 2015, Gastroenterology.

[20]  W. Polonsky,et al.  When Does Personalized Feedback Make A Difference? A Narrative Review of Recent Findings and Their Implications for Promoting Better Diabetes Self-Care , 2015, Current Diabetes Reports.

[21]  A. Burt,et al.  Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management. , 2015, Journal of hepatology.

[22]  M. Mcdermott,et al.  Low Awareness of Nonalcoholic Fatty Liver Disease Among Patients at High Metabolic Risk , 2015, Journal of clinical gastroenterology.

[23]  N. Alkhouri,et al.  Liver transplantation for nonalcoholic fatty liver disease: new challenges and new opportunities. , 2014, World journal of gastroenterology.

[24]  B. Lambe,et al.  Engaging ‘hard to reach’ men in community based health promotions , 2014 .

[25]  A. House,et al.  A qualitative synthesis of factors influencing maintenance of lifestyle behaviour change in individuals with high cardiovascular risk , 2013, BMC Cardiovascular Disorders.

[26]  G. Targher,et al.  Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis , 2013, Nature Reviews Gastroenterology &Hepatology.

[27]  D. Szosland Shift work and metabolic syndrome, diabetes mellitus and ischaemic heart disease. , 2010, International journal of occupational medicine and environmental health.

[28]  L. Goodyear,et al.  Signaling mechanisms in skeletal muscle: Acute responses and chronic adaptations to exercise , 2008, IUBMB life.

[29]  P. Sainsbury,et al.  Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. , 2007, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[30]  M. Rodríguez,et al.  Motivational factors and physician advice for physical activity in older urban adults. , 2007, Journal of aging and physical activity.

[31]  V. Braun,et al.  Using thematic analysis in psychology , 2006 .

[32]  J. Dixon,et al.  Preoperative weight loss with a very-low-energy diet: quantitation of changes in liver and abdominal fat by serial imaging. , 2006, The American journal of clinical nutrition.

[33]  B. R. Schlenker,et al.  Social anxiety and self-presentation: a conceptualization and model. , 1982, Psychological bulletin.